Skip to content

Topics: Medicine

  • Advanced X-ray technology tells us more about Ménière's disease

    The organ of balance in the inner ear is surrounded by the hardest bone in the body. Using synchrotron X-rays, researchers at Uppsala University have discovered a drainage system that may be assumed to play a major role in the onset of Ménière's disease, a common and troublesome disorder. These results are published in the journal Scientific Reports.

  • AI - a New Tool for Cardiac Diagnostics

    Artificial intelligence (AI) may be an aid to interpreting ECG results, helping healthcare staff to diagnose diseases that affect the heart. Researchers at Uppsala University and heart specialists in Brazil have developed an AI that automatically diagnoses atrial fibrillation and five other common ECG abnormalities just as well as a cardiologist.

  • Lymphatic vessels in mice and humans: alike yet different

    In an international collaboration, researchers from Uppsala University have mapped the lymph node lymphatic vessels in mice and humans down to the level of individual cells. The results may eventually help scientists to discover new methods for strengthening the immune system against viruses and cancer. Their work has been published in the journal Frontiers of Cardiovascular Research.

  • Type 2 diabetes: Too much glucagon when α-cells become insulin resistant

    Patients with type 2 diabetes secrete not only too little insulin but also too much glucagon, which contributes to poor blood glucose control. A new study from Uppsala University suggests that this is because the glucagon-secreting α-cells have become resistant to insulin.

  • Changes in cellular degradation hubs can lead to cancer

    Cancer cells grow and divide in an uncontrolled manner. A new study from Uppsala University now shows how alterations in a cell’s degradation hubs, called lysosomes, can cause abnormal cell growth. The results are published today in the scientific journal Nature Communications.

  • Careless cancer cells may be susceptible to future drugs

    Could the ability of cancer cells to quickly alter their genome be used as a weapon against malignant tumours? Researchers at Uppsala University have succeeded in developing a substance that has demonstrated promising results in experiments on both animal models and human cancer cells. The study is published in the journal Nature Communications.

  • “Lethal” mutation made tuberculosis bacteria resistant to important antibiotic

    Antibiotic-resistant tuberculosis is a common and serious problem globally. In a new article, researchers from Uppsala University describe how tuberculosis bacteria that carries a mutation that in theory should kill them manages to stay alive. The researchers discovered that the same trick that kept the bacteria alive also made them resistant to a very important type of antibiotic.

  • Study finds losing a night of sleep may increase blood levels of Alzheimer’s biomarker

    A preliminary study by researchers at Uppsala University has found that when young, healthy men were deprived of just one night of sleep, they had higher levels of tau – a biomarker for Alzheimer’s disease – in their blood than when they had a full, uninterrupted night of rest. The study is published in the medical journal Neurology.

  • Smart algorithm finds possible future treatment for childhood cancer

    Using a computer algorithm, scientists at Uppsala University have identified a promising new treatment for neuroblastoma. This form of cancer in children, which occurs in specialised nerve cells in the sympathetic nervous system, may be life-threatening.

  • Whole-genome sequencing analysis helps in finding more exact biomarkers

    A new study from Uppsala University shows that whole-genome sequencing increases the precision of genetic studies, which in turn can improve our understanding of how to use biomarkers to discover disease. The results are published in the scientific journal Scientific Reports.

  • Marked divergence in inhalers’ carbon footprint

    In a new study, researchers at Uppsala University compared the carbon footprint of two kinds of inhaler used for treating asthma and chronic obstructive pulmonary disease: dry powder inhalers and sprays containing propellants. The results show that treatment with spray inhalers has a carbon footprint 20 times greater than that of using dry powder inhalers.

  • New mechanism for dysfunctional insulin release identified

    In a new study, researchers at Uppsala University have identified a previously unknown mechanism that regulates release of insulin, a hormone that lowers blood glucose levels, from the β-cells (beta cells) of the pancreas. This mechanism is disrupted in type 2 diabetes. The scientists hope this finding will be used to develop new treatments against the disease.

  • Deaths halved among infarct patients attending Heart School

    ​Patients who attend ‘Heart School’, as almost every patient is invited to do after a first heart attack, live longer than non-participating patients. This is shown in a new study, by researchers at Uppsala University, published in the European Journal of Preventive Cardiology.

  • New WHO autoantibody reference reagent will benefit SLE patients

    Reference reagents are important in diagnostics and care of patients with systemic lupus erythematosus (SLE). An international team of researchers now presents a WHO autoantibody reference reagent that will help to align autoantibody analyses and thus to optimise diagnosis and treatment to patients irrespective of where they live. The findings are published in Annals of the Rheumatic Diseases.

  • Novel method identifies the right individual exosomes

    There is a growing demand for diagnostic markers for early disease detection and prognosis. Exosomes are potential biomarkers for cancer progression and neurodegenerative disease but it can be difficult to identify what tissue a specific exosome comes from. Researchers have solved this problem by developing a method that maps surface protein complements on large numbers of individual exosomes.

  • Studies of fungi provide new knowledge of harmful mutations in cells

    Long-lived mushrooms that grow in ‘fairy rings’ accumulate surprisingly few mutations over time. This finding indicates that their protection against harmful mutations is well developed. The results, to be published in the esteemed journal Current Biology, are interesting in terms of both medicine and evolutionary biology.

  • Multiple genes affect risk of asthma, hay fever and eczema

    In a new study from SciLifeLab at Uppsala University, researchers have found a total of 141 regions (genes) in our genetic material that largely explain the genetic risk underlying asthma, hay fever and eczema. As many as 41 of the genes identified have not previously been linked to an elevated risk for these diseases. The results are published in the scientific journal Human Molecular Genetics.

  • New genes out of nothing

    One key question in evolutionary biology is how novel genes arise and develop. Swedish researchers now show how new genes and functions that are advantageous to bacteria can be selected from random DNA sequences. The results are presented in the scientific journal mBio.

  • Inhibition of ribosome biogenesis as a novel approach for multi-stage cancer treatment

    Nearly ninety per cent of all cancer patient deaths are due to metastasis. A study from Uppsala University shows that a process that allows the cells to metastasise is aided by the synthesis of new ribosomes, the cell components in which proteins are produced. The results open the possibility for new treatment strategies for advanced cancers. The study is published in Nature Communications.

Show more